Alex Zhavoronkov
Dr. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a biotechnology company that specializes in using artificial intelligence to accelerate drug discovery and development. Under his leadership, the company has pioneered the use of generative AI in pharmaceuticals, resulting in the creation of numerous potential drug candidates. His vision focuses on integrating advanced technologies to improve healthcare outcomes and the efficiency of scientific research.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 7.00 | 0.12% | +0% | 331,002,651 | 395,463 | $21,000,000 | 25,090$ |
| Totals | 1 | 331,002,651 | 395,463 | $21,000,000 | 25,090$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine, discussed a drug being developed to treat a serious lung disease.
7
Vietnam:
Dr. Alex Zhavoronkov, the founder and CEO of Insilico Medicine, stated that the humanoid robot will work alongside scientists.
8